Structural Insights into Dopamine Receptor–Ligand Interactions: From Agonists to Antagonists
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.4c00295 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Emmanuel D Barbosa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States. Hauptthemen laut MEDLINE: Dopamine Agonists, Dopamine Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Advancing a Healthier Wisconsin Endowment, Medical College of Wisconsin.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.
ORCID-Profile: Emmanuel D Barbosa, Heather E Clift
Förderung
- NIGMS NIH HHS
- Advancing a Healthier Wisconsin Endowment
- Medical College of Wisconsin
- National Institute of General Medical Sciences
Zitieren
APA
Barbosa, E. D., Ma, Y., Clift, H. E., Olson, L. J., Zhu, L., & Liu, W. (2024). Structural Insights into Dopamine Receptor–Ligand Interactions: From Agonists to Antagonists. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00295
Vancouver
Barbosa ED, Ma Y, Clift HE, Olson LJ, Zhu L, Liu W. Structural Insights into Dopamine Receptor–Ligand Interactions: From Agonists to Antagonists. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00295
BibTeX
@article{Barbosa2024,
author = {Barbosa, Emmanuel D and Ma, Yuanyuan and Clift, Heather E and Olson, Linda J and Zhu, Lan and Liu, Wei},
title = {Structural Insights into Dopamine Receptor–Ligand Interactions: From Agonists to Antagonists},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.4c00295}
}
EUVIMED